VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Combined VEGFR and MAPK pathway inhibition in angiosarcoma.
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance.
State of the science: Emerging therapeutic strategies for targeting angiogenesis in ovarian cancer.
Why stress is BAD for cancer patients.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Combined VEGFR and MAPK pathway inhibition in angiosarcoma.
Combined VEGFR and MAPK pathway inhibition in angiosarcoma. Sci Rep. 2021 04 30; 11(1):9362.
View in:
PubMed
subject areas
Animals
Antineoplastic Combined Chemotherapy Protocols
Apoptosis
Biomarkers, Tumor
Cell Proliferation
Gene Expression Regulation, Neoplastic
Hemangiosarcoma
Humans
MAP Kinase Signaling System
Mice
Mice, Nude
Prognosis
Pyridones
Pyrimidinones
Quinazolines
Transcriptome
Tumor Cells, Cultured
Vascular Endothelial Growth Factor Receptor-2
Xenograft Model Antitumor Assays
authors with profiles
ANIL K SOOD
LINGEGOWDA SELANERE MANGALA
ALEXANDER LAZAR
VINOD RAVI